These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38334732)

  • 21. 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
    Hirata T; Kinoshita M; Tamari K; Seo Y; Suzuki O; Wakai N; Achiha T; Umehara T; Arita H; Kagawa N; Kanemura Y; Shimosegawa E; Hashimoto N; Hatazawa J; Kishima H; Teshima T; Ogawa K
    J Neurosurg; 2019 Sep; 131(3):676-686. PubMed ID: 30239314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differential diagnosis of brain gliomas by positron emission tomography using various radiopharmaceuticals].
    Kostenikov NA; Tiutin LA; Fadeev NP; Panfilenko AF; Zykov EM; Iliushchenko IuR; Makeeva OIu
    Vestn Rentgenol Radiol; 2014; (5):13-8. PubMed ID: 25775890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
    Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-evaluation of the diagnostic performance of
    Kim D; Chun JH; Kim SH; Moon JH; Kang SG; Chang JH; Yun M
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1678-1684. PubMed ID: 31102001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas.
    D'Souza MM; Sharma R; Jaimini A; Panwar P; Saw S; Kaur P; Mondal A; Mishra A; Tripathi RP
    Clin Nucl Med; 2014 Sep; 39(9):791-8. PubMed ID: 25036022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
    Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
    J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
    Mahasittiwat P; Mizoe JE; Hasegawa A; Ishikawa H; Yoshikawa K; Mizuno H; Yanagi T; Takagi R; Pattaranutaporn P; Tsujii H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):515-22. PubMed ID: 17900820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas.
    Poetsch N; Woehrer A; Gesperger J; Furtner J; Haug AR; Wilhelm D; Widhalm G; Karanikas G; Weber M; Rausch I; Mitterhauser M; Wadsak W; Hacker M; Preusser M; Traub-Weidinger T
    Neuro Oncol; 2018 Feb; 20(3):411-419. PubMed ID: 29016947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016.
    Kebir S; Weber M; Lazaridis L; Deuschl C; Schmidt T; Mönninghoff C; Keyvani K; Umutlu L; Pierscianek D; Forsting M; Sure U; Stuschke M; Kleinschnitz C; Scheffler B; Colletti PM; Rubello D; Rischpler C; Glas M
    Clin Nucl Med; 2019 Mar; 44(3):214-220. PubMed ID: 30516675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic study of supratentorial gliomas with L-methyl-11C-methionine and positron emission tomography.
    Lilja A; Bergström K; Hartvig P; Spännare B; Halldin C; Lundqvist H; Långstrom B
    AJNR Am J Neuroradiol; 1985; 6(4):505-14. PubMed ID: 2992257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.
    Torii K; Tsuyuguchi N; Kawabe J; Sunada I; Hara M; Shiomi S
    Ann Nucl Med; 2005 Dec; 19(8):677-83. PubMed ID: 16444993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T2-FLAIR mismatch sign correlates with
    Ebiko Y; Tamura K; Hara S; Inaji M; Tanaka Y; Nariai T; Ishii K; Maehara T
    J Neurooncol; 2023 Aug; 164(1):257-265. PubMed ID: 37589920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours.
    Cicuendez M; Lorenzo-Bosquet C; Cuberas-Borrós G; Martinez-Ricarte F; Cordero E; Martinez-Saez E; Castell-Conesa J; Sahuquillo J
    Clin Neurol Neurosurg; 2015 Dec; 139():328-33. PubMed ID: 26588352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET.
    Yamamoto Y; Nishiyama Y; Kimura N; Kameyama R; Kawai N; Hatakeyama T; Kaji M; Ohkawa M
    Mol Imaging Biol; 2008 Sep; 10(5):281-7. PubMed ID: 18543041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography.
    Shinozaki N; Uchino Y; Yoshikawa K; Matsutani T; Hasegawa A; Saeki N; Iwadate Y
    J Neurosurg; 2011 Jun; 114(6):1640-7. PubMed ID: 21214332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The accumulation of 11C-methionine in cerebral glioma patients studied with PET.
    Kameyama M; Shirane R; Itoh J; Sato K; Katakura R; Yoshimoto T; Hatazawa J; Itoh M; Ido T
    Acta Neurochir (Wien); 1990; 104(1-2):8-12. PubMed ID: 2386094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.
    Kato T; Shinoda J; Nakayama N; Miwa K; Okumura A; Yano H; Yoshimura S; Maruyama T; Muragaki Y; Iwama T
    AJNR Am J Neuroradiol; 2008 Jun; 29(6):1176-82. PubMed ID: 18388218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study on EGFR-targeted molecular imaging of PET/CT With 11C-PD153035 in human gliomas.
    Sun J; Cai L; Zhang K; Zhang A; Pu P; Yang W; Gao S
    Clin Nucl Med; 2014 Jan; 39(1):e20-6. PubMed ID: 24335566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.